Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability. | J Transl Med | 2014 | 24965703 | PubTator, text mining | PubMed |
| Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival. | Clin Cancer Res | 2014 | 24963048 | PubTator, text mining | PubMed |
| Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer. | Oncotarget | 2014 | 24962213 | PubTator, text mining | PubMed |
F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6). | J Biol Chem | 2014 | 24936062 | Swiss-Prot, curated | PubMed |
| Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. | Pharmacol Ther | 2014 | 24924700 | PubTator, text mining | PubMed |
| Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells. | BMC Microbiol | 2014 | 24906853 | PubTator, text mining | PubMed |
| A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy. | Autophagy | 2014 | 24906121 | PubTator, text mining | PubMed |
| Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders. | PLoS One | 2014 | 24892279 | PubTator, text mining | PubMed |
| Involvement of p38 in signal switching from autophagy to apoptosis via the PERK/eIF2α/ATF4 axis in selenite-treated NB4 cells. | Cell Death Dis | 2014 | 24874742 | PubTator, text mining | PubMed |
| Counter-regulation of T cell effector function by differentially activated p38. | J Exp Med | 2014 | 24863062 | PubTator, text mining | PubMed |
| Alkyl chain substituted 1,9-pyrazoloanthrones exhibit prominent inhibitory effect on c-Jun N-terminal kinase (JNK). | Org Biomol Chem | 2014 | 24853961 | PubTator, text mining | PubMed |
| The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways. | J Immunol | 2014 | 24842757 | PubTator, text mining | PubMed |
| Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data. | Breast Cancer Res Treat | 2014 | 24839032 | PubTator, text mining | PubMed |
| Small molecule inhibitors targeting activator protein 1 (AP-1). | J Med Chem | 2014 | 24831826 | PubTator, text mining | PubMed |
| Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth. | PLoS Genet | 2014 | 24831815 | PubTator, text mining | PubMed |
| Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology. | Assay Drug Dev Technol | 2014 | 24831789 | PubTator, text mining | PubMed |
| CAMK1 phosphoinositide signal-mediated protein sorting and transport network in human hepatocellular carcinoma (HCC) by biocomputation. | Cell Biochem Biophys | 2014 | 24825433 | PubTator, text mining | PubMed |
| Blockade of CD26 signaling inhibits human osteoclast development. | J Bone Miner Res | 2014 | 24821427 | PubTator, text mining | PubMed |
| Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. | Trends Biochem Sci | 2014 | 24818748 | PubTator, text mining | PubMed |
| Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade. | Chem Biol Interact | 2014 | 24814888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=73